Tag: physical sciences
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.
-
Univ. Spin-Off Develops New Cybersecurity Paradigm
A start-up enterprise from a university is developing a simplified cybersecurity infrastructure for businesses, and raised $2 million in its first funding round
-
Nanoparticles, Peroxide Boost Tooth Decay Prevention
Adding iron oxide nanoparticles to hydrogen peroxide is shown to reduce the build-up of bacterial films on teeth, preventing cavities from forming in lab rats.
-
Patch Delivers Gene, Drug, Heat Therapies to Colon Tumors
Engineers developed a hydrogel patch with three types of therapy applied directly to tumors in the colon, which in lab mice caused cancer to go into remission.
-
Trial Shows 5-Year Retinal Implant Safety, Efficacy
A device implanted people with retinitis pigmentosa shows after 5 years the device provides visual function to recipients, largely without adverse effects.
-
Microneedle System Designed for Drug Monitoring
Researchers designed a device that measures drug concentrations in patients with tiny microneedles on the skin rather than frequent invasive blood tests.
-
Software Developed to Quantify Single Cells Over Time
A team of computational biologists and engineers in Europe developed software that analyzes the growth and changes in individual cells over time.
-
Stem Cells, Gene Therapy Produce Replacement Joint Cartilage
A process combining stem cells, industrial weaving, and gene therapy to grow replacement cartilage for osteoarthritis also prevents inflammation from returning.
-
Nanotech Imaging Start-Up Raises $3M in Seed Financing
A spin-off enterprise from University of California-Berkeley, developing an imaging technology with magnetic nanoparticles, is raising $3 million in funding.
-
High-Volume, More Efficient Stem Cell Production Developed
An academic-industry team in Europe designed and tested new processes that can simplify and streamline production of human stem cells in large quantities.